Xcout IntelSign inSubscribe

Hikal Limited

HIKALPharmaceuticalsNavi Mumbai, India

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Subscribe to see Hikal Limited’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Hikal Limited at a glance

Hikal Limited is a pharmaceuticals company headquartered in Navi Mumbai, India. It is publicly listed (HIKAL) with a market capitalisation of $274.4M. Xcout tracks 11 named people at Hikal Limited, including Amit Kalyani (Deputy Managing Director of Bharat Forge Limited).

Industry
Pharmaceuticals
Headquarters
Navi Mumbai, India
Market cap
$274.4M
Employees
3,595
Ticker
HIKAL

Hikal Limited leadership

  • Amit KalyaniDeputy Managing Director of Bharat Forge Limited
  • Sameer HiremathVice Chairman and Managing Director
  • Shivani SachdevaFounder & CEO of India Alternatives
  • Jai HiremathFounder and Executive Chairman
  • Ravi KapoorPromoter-Director
  • Sarangan SureshSenior Vice President Operations

5 more named people on record for Hikal Limited, with roles, board committees and tenure — see the full roster →

Hikal Limited competitors

A few of Hikal Limited's closest competitors — see the full list of competitors and alternatives →

Solara Active Pharma Sciences LimitedSOLARA · PharmaceuticalsChennai, India
68% matchPublic

Solara Active Pharma Sciences Limited is an Indian-based pharmaceutical company primarily involved in the comprehensive development, production, and global trade of active pharmaceutical ingredients (APIs). Their activities span the manufacturing, processing, sale, import, and export of these essential drug components. The company's extensive product range includes APIs designed for a wide spectrum of therapeutic applications, such as anesthetics, antibiotics, antivirals, cardiovascular agents, central nervous system treatments, anti-inflammatory drugs, and treatments for metabolic disorders like type-II diabetes, among numerous other specialized categories. Beyond its core product offerings, Solara also delivers specialized contract research and manufacturing services (CRAMS) for APIs. These services encompass custom development and manufacturing, analytical support, impurity synthesis, and comprehensive regulatory assistance. The company maintains a significant international presence, exporting its products and conducting operations across diverse global regions, including the Asia Pacific, Europe, North America, and South America. Headquartered in Chennai, India, Solara Active Pharma Sciences Limited was established in 2017. Initially known as SSL Pharma Sciences Limited, the company adopted its current name in March of the same year.

Market cap$256.9M
Employees2,156
Solara Active Pharma Sciences Limited competitors & alternatives →

Get Hikal Limited's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Hikal Limited — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Hikal Limited in Xcout Intel

  • 11 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →